Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
about
Management of Membranous Nephropathy in AsiaAlternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous NephropathyNephrotic syndrome: what's new, what's hot?Autoantibodies in renal diseases - clinical significance and recent developments in serological detectionAntiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous NephropathyRituximab use in adult primary glomerulopathy: where is the evidence?Enigma (partially) resolved: phospholipase A2 receptor is the cause of "idiopathic" membranous glomerulonephritisInsights into kidney diseases from genome-wide association studies.Analysis of 4931 renal biopsy data in central China from 1994 to 2014.HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy.A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.American Society of Nephrology quiz and questionnaire 2014: glomerular diseasesIncreased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy.Mitochondrial-dependent Autoimmunity in Membranous Nephropathy of IgG4-related Disease.Membranous Nephropathy: The Journey Continues …Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers.Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous NephropathyAnti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus-Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study.Pharmacological treatment of primary membranous nephropathy in 2016.PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy.Changing the concepts of immune-mediated glomerular diseases through proteomics.Characterization of glomerular extracellular matrix by proteomic analysis of laser-captured microdissected glomeruli.Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivityMembranous Nephropathy: A Journey From Bench to BedsideAutoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.Prevalence of serum anti M-type phospholipase A2 receptor antibody in primary membranous nephropathy: A single center experienceMotor neuron-derived Thsd7a is essential for zebrafish vascular development via the Notch-dll4 signaling pathway.Membranous nephropathy: Pilot study of a novel regimen combining cyclosporine and Rituximab.Immunohistochemical Glomerular Expression of Phospholipase A2 Receptor in Primary and Secondary Membranous Nephropathy: A Retrospective Study in an Indian Cohort with Clinicopathological Correlations.Biomarkers to detect membranous nephropathy in Chinese patients.Recent advances in the understanding of immune-mediated nephrotic syndrome: diagnostic and prognostic implications.Proteomics and autoimmune kidney disease.The Influence and Role of Microbial Factors in Autoimmune Kidney Diseases: A Systematic Review.Decade in review--glomerular disease: The glomerulus reveals some secrets.Immunology of membranous nephropathy: from animal models to humans.Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.A Rare Adult Case with Diffuse Segmental Membranous Glomerulonephritis.
P2860
Q26740481-084BF41A-61C4-438F-9005-06DD3875EDBDQ26747416-D183FBE1-97D4-4BE1-8B83-4B794A4CBBFCQ26782879-2842FE61-1AC7-4718-8291-D6F6D1ED5B6EQ26849664-4E66C832-3768-43A5-9EA3-BBDDF6B2B486Q27023372-BFA7D43F-A701-44D2-BE67-791CFE7B5591Q28075564-DEF45E29-E0F7-453B-9910-3C0921998232Q28083035-B4E7815B-C954-4376-81A6-C4DB211F3ED4Q30248678-ACF2F845-0B1F-4C65-A54D-E9919BCC5FACQ31097085-E7F2D023-1B80-4730-A215-70DA7F487DE0Q33595271-57BBDABC-A204-497B-8285-B06EBFF647C4Q33844319-D095B817-E4B3-4CDC-85D8-312E0B3551CFQ35278674-6C91E605-0F95-4801-84E3-612365330BE9Q35754366-147EFB32-397F-4354-8109-8F66465B9894Q35782970-B651AF8D-828E-4195-9E9D-3BEFDC4BF9F6Q35799662-0D6022A8-FF90-43DE-A9FB-D9300AA9C5FEQ35800770-1B95D195-2950-4386-B55A-FF380E043172Q35862682-FB8114E5-CD07-4B30-ACCB-9D999330CC56Q36029138-01AE6C87-0386-4F0E-98D1-500F10DE356DQ36063886-E3441DFF-3EF2-4E0E-BC82-E55543735D03Q36088887-3CB41E87-1A3A-404D-AB04-F3B08D49D3B8Q36106413-EA6C448C-A92D-4E2C-B6B8-435D57D4311EQ36201382-2B73F03D-00D4-4232-962B-F789B684F680Q36201993-28B40517-A141-4FF0-949A-09644CEF124FQ36227362-BD21B985-47B1-488E-808F-E5DFC8D40DDAQ36296621-2EFC3760-5779-424B-A66A-CF0E6BE6107FQ36764775-601F41DB-7CB7-4D88-82C4-3DFE90ACD308Q37038576-FB577386-14DD-44D1-ABB8-E2608274BACCQ37042246-7E8199C0-D02A-4B61-8CAD-2A6ED972AEB2Q37135113-2B06B4A6-71DB-4903-A8C5-B8C3B62275B7Q37148339-BF2C2F08-D4A1-4F87-A776-FA0700363C14Q37475696-E719A842-5F21-4547-B92C-C472AB3770ECQ37695117-D0B50B82-3468-4B4C-B899-C0965A81880EQ37708722-8B75DA33-91EA-4EDA-A88A-815CAF5498ADQ38371343-8AD4760C-3561-4BF5-80FB-D07D3F438A25Q38483988-3897E374-9342-4BE8-84ED-0B6EEE876571Q38528984-D316D00B-2901-4958-9B82-073D99E6C825Q38586603-730C72FC-DABC-401E-9A7B-072A1CFD16D6Q38605469-F3028FDB-56C3-4222-8DDF-A04345B67CB6Q38680011-A70DD425-8F76-41F6-9071-11055357F265Q38695156-E155195F-EADE-496E-846F-F95E6EE53490
P2860
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@ast
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@en
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@nl
type
label
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@ast
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@en
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@nl
prefLabel
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@ast
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@en
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@nl
P2093
P2860
P356
P1476
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.
@en
P2093
Anne-Sophie Dabert-Gay
Barbara Seitz-Polski
Catherine Meyer-Schwesinger
Delphine Debayle
Elion Hoxha
Guillaume Dolla
Gunther Zahner
Laurence H Beck
P2860
P304
P356
10.1056/NEJMOA1409354
P407
P577
2014-11-13T00:00:00Z